MedPath

Assessment of the Effect of an Implant System With a Novel Abutment Attachment Design on Crestal Bone Preservation

Not Applicable
Completed
Conditions
Partial Edentulism
Tooth Disease
Interventions
Device: Nanotite Certain Tapered implant
Device: New Abutment Connection implant
Registration Number
NCT01529879
Lead Sponsor
ZimVie
Brief Summary

Integration success rates and the preservation of crestal bone will be higher for the experimental device than for the control implants.

Detailed Description

In this study patients are randomized to receive either the experimental implant system or the control Nanotite Certain Tapered (standard abutment connection) and assessed for integration success measured by lack of implant mobility and lack of bone loss obtained at various study time points

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • patients of either sex and older than 18 years of age
  • patients needing at least one dental implant to treat partial edentulism
  • patients physically able to tolerate surgical and restorative dental procedures
  • patients agreeing to all protocol visits
Exclusion Criteria
  • patients with infection or severe inflammation at the intended treatment sites
  • patients smoking greater than 10 cigarettes per day
  • patients with uncontrolled diabetes mellitus
  • patients with uncontrolled metabolic diseases
  • patients who received radiation treatment to the head in the past 12 months
  • patients needing bone grafting at the intended treatment sites
  • patients known to be pregnant at screening visit
  • patients with para-functional habits like bruxing and clenching

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nanotite Certain Tapered implantNanotite Certain Tapered implantNanotite Certain Tapered (standard abutment connection) implant
New abutment connection implantNew Abutment Connection implantImplant with new abutment connection
Primary Outcome Measures
NameTimeMethod
Cumulative success rate2 years

Crestal bone regression (amount of bone loss measured) and equivalence in integration success (implant mobility)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UNICOC

🇨🇴

Bogota, Colombia

© Copyright 2025. All Rights Reserved by MedPath